Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances Insights from the Society of Infectious Diseases Pharmacists
出版年份 2011 全文链接
标题
Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances Insights from the Society of Infectious Diseases Pharmacists
作者
关键词
-
出版物
PHARMACOTHERAPY
Volume 31, Issue 4, Pages 357-368
出版商
Wiley
发表日期
2011-03-26
DOI
10.1592/phco.31.4.357
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C
- (2009) Luz Martin-Carbonero et al. AIDS
- HCV-NS3 inhibitors: Determination of their kinetic parameters and mechanism
- (2009) María Victoria Flores et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus–Coinfected Patients with Advanced Immunosuppression
- (2009) José A. Mira et al. CLINICAL INFECTIOUS DISEASES
- Boceprevir, an NS3 Protease Inhibitor of HCV
- (2009) Kenneth Berman et al. Clinics in Liver Disease
- Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
- (2009) Simone Susser et al. HEPATOLOGY
- Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks
- (2009) Fumitaka Suzuki et al. HEPATOLOGY RESEARCH
- Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus Coinfection
- (2009) Milos Opravil et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Risk of Hepatitis-Related Mortality Increased Among Hepatitis C Virus/HIV-Coinfected Drug Users Compared With Drug Users Infected Only With Hepatitis C Virus
- (2009) Colette Smit et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Pegylated interferon 2a plus ribavirin versus pegylated interferon 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
- (2009) J. Berenguer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- PEG IFN alfa-2a vs. alfa-2b: And the winner is …?
- (2009) Antonio Craxì JOURNAL OF HEPATOLOGY
- HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension
- (2009) T. Reiberger et al. JOURNAL OF VIRAL HEPATITIS
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
- (2008) Hla-Hla Thein et al. AIDS
- Hepatitis C Virus Coinfection Does Not Affect CD4 Restoration in HIV-Infected Patients after Initiation of Antiretroviral Therapy
- (2008) Kari Yacisin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Progression of Fibrosis in HIV and Hepatitis C Virus-Coinfected Patients Treated with Interferon plus Ribavirin-Based Therapy: Analysis of Risk Factors
- (2008) F. Bani-Sadr et al. CLINICAL INFECTIOUS DISEASES
- Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study
- (2008) Ellen Tedaldi et al. CLINICAL INFECTIOUS DISEASES
- Randomized trial comparing pegylated interferon α-2b versus pegylated interferon α-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients
- (2008) Montserrat Laguno et al. HEPATOLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults
- (2008) JK Rockstroh et al. HIV MEDICINE
- Therapeutical Aspects and Outcome of HIV/HCV Coinfected Patients Treated with Pegylated Interferon plus Ribavirin in an Italian Cohort
- (2008) E. Righi et al. INFECTION
- Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
- (2008) J. A. Mira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects
- (2008) Doug J. Bartels et al. JOURNAL OF INFECTIOUS DISEASES
- Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors
- (2008) F. Bani-Sadr et al. JOURNAL OF VIRAL HEPATITIS
- Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
- (2008) M. Núñez et al. JOURNAL OF VIRAL HEPATITIS
- Viral hepatitis and HIV coinfection
- (2007) Mark S. Sulkowski JOURNAL OF HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started